Emerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer

About this episode

Amit Mahipal and Shubham Pant discuss new therapies for HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer.

Listen to Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss the new and emerging therapies for the individualized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer.

People in this episode

Guests: Amit Mahipal, MD, MPH, Shubham Pant, MD

Topics covered

• emerging therapies
• HER2-positive cancer
• gastroesophageal adenocarcinoma
• biliary tract cancer
• individualized care

Keywords

• HER2-positive
• gastroesophageal adenocarcinoma
• biliary tract cancer
• emerging therapies
• individualized care

Mentioned in this episode

Organizations: Decera Clinical Education

Books & works: HER2+ Gastroesophageal Adenocarcinoma, Biliary Tract Cancer

More episodes of Decera Clinical Education Oncology Podcast

• Advancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligibility, and Awareness · June 9, 2026 · 27 min
• HNSCC: Current and Emerging Therapeutic Strategies · May 29, 2026 · 26 min
• Navigating Relapsed/Refractory Multiple Myeloma: Real-world Use of Bispecific Antibodies · May 15, 2026 · 21 min
• Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma · May 7, 2026 · 31 min
• Thrombotic Events and ET/PV: What You Should Know · April 30, 2026 · 22 min
• Global Experts Discuss Current and Emerging Treatments for ET and PV · April 30, 2026 · 17 min